What sector does SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. belong to?

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. operates in the Industrials sector, specifically the Services industry, and is listed on the US markets.

What is the current share price of 2395?

As of the latest available quote, 2395 traded at ¥1,305.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 2395?

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. has a price-to-earnings (P/E) ratio of about 11.89. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 2395?

The market capitalisation of SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. is approximately ¥54.33B.

Is SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. profitable?

For its latest reported financial year, SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. recorded a net profit margin of about 14.04%.

Does 2395 pay a dividend?

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. currently has a dividend yield of about 3.78%.

What is the return on equity (ROE) of 2395?

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. has a return on equity (ROE) of about 11.00%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 2395?

Over the past 52 weeks, 2395 has traded between a low of ¥1,067.00 and a high of ¥2,005.00.

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.

2395 TSE Industrials Services

TSE Prime

¥1,305.00

-1.29%

Delayed · cached 15 min

Fair value analysis

2395

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.

¥1,305.00

Close used for this calculation

¥1,372.55Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

62/100

Profitability14/25

Returns14/25

Balance Sheet9/25

Efficiency25/25

Growth13/25

Good

Quality radar

Consensus fair value

¥1,372.55

Near FV

▲ +5.2% against the close used

Model range ¥454.73 – ¥2,193.80

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥454.73Fair value¥1,372.55Bull¥2,193.80

FairClose

52-week traded range

52W low ¥1,079.0052W high ¥1,952.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. closed at ¥1,305.00, 4.9% below the consensus fair value of ¥1,372.55 drawn from 9 valuation models.

Financial DNA score 62/100 — Good. P/E of 11.9x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

¥1,419.47

+8.8%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

¥1,598.80

+22.5%

√(22.5 × EPS × BVPS)

EPS=109.69, BVPS=1035.71

P/E Fair Value

¥2,193.80

+68.1%

EPS × 20x (sector P/E)

EPS=109.69, Sector P/E=20x

Peter Lynch (PEG)

¥1,155.04

-11.5%

EPS × Growth% (PEG = 1 is fair)

EPS=109.69, g=10.5%

EV/EBITDA

¥454.73

-65.2%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=5.97B

Dividend Discount (DDM)

¥637.26

-51.2%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=49.98, r=10%, g=2%

Book Value (P/B)

¥1,183.67

-9.3%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=1035.71, ROE=11%, g=3%, r=10%

Reverse DCF

¥1,305.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 0.1% | Historical: -10.5%

Margin of Safety

¥1,303.02

-0.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=1737.36, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer